Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd. (NASDAQ:CLBT), filed a Form 4 on August 24, 2026, reporting the disposition of 12,562 ordinary shares on August 21, 2026, in connection with tax obligations arising from the vesting of restricted stock units.
Key Highlights
- Reporting person: Marcus Jewell, Global Chief Revenue Officer of Cellebrite DI Ltd.
- Shares disposed: 12,562 ordinary shares (par value NIS 0.00001) on August 21, 2026, coded as a sale (S).
- Weighted average price: $11.2416 per share, with individual transactions ranging from $11.16 to $11.30, inclusive.
- RSU origin: The disposed shares were granted on November 15, 2023, as restricted stock units; the disposition is described as associated with tax obligations related to vesting.
- Post-transaction ownership: Jewell directly owns 427,128 ordinary shares following the reported transaction.
Cellebrite CRO Files RSU-Related Share Disposition in August 2026
According to the filing, Marcus Jewell, serving as Global Chief Revenue Officer of Cellebrite DI Ltd., disposed of 12,562 ordinary shares on August 21, 2026. The filing describes the disposition as "associated with tax obligations of the reporting person associated with the vesting of the RSUs," which were originally granted on November 15, 2023. The transaction was assigned code "S" in Table I of the Form 4.
The filing reports a weighted average sale price of $11.2416 per share. As noted in the explanatory footnotes, the shares were sold across multiple transactions at prices ranging from $11.16 to $11.30, inclusive. The filing further states that Jewell "undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."
Following the reported transaction, Jewell directly holds 427,128 ordinary shares of Cellebrite DI Ltd. No derivative securities transactions were reported in Table II of the filing. The Form 4 was filed by one reporting person and is not identified as an amendment to a prior filing.
What Was Disclosed
The filing discloses a sale of 12,562 Cellebrite ordinary shares by the company's Global Chief Revenue Officer on August 21, 2026, at a weighted average price of $11.2416, linked to tax obligations from RSU vesting, leaving the officer with 427,128 shares directly held.



Please wait processing your request...